BioSpace News Archive

CytoDyn Shows U.S. Senate Field Rep That HIV/AIDS Is Still A Serious Problem In America

August 17, 2006
·
1 min read
Pharm Country

Millennium Biotechnologies Group, Inc. Enters Into Agreement For $2.6 Million Private Placement

August 17, 2006
·
1 min read
Drug Development

Hana Biosciences, Inc. Initiates Marqibo(R) Phase II Clinical Trial In Relapsed Or Refractory Acute Lymphoblastic Leukemia (ALL)

August 17, 2006
·
1 min read
Lone Star Bio

Management Team Of Amarillo Biosciences, Discuss Upcoming Studies And Successful Passing Of FDA’s 30-day Review Process For Company’s Investigational New Drug Application For Idiopathic Pulmonary Fibrosis At SmallCapVoice.com

August 17, 2006
·
1 min read
Drug Development

ProEthic Pharmaceuticals, Inc. Announces Positive Phase I Trial Results For Fast-Acting Acute Pain Product Candidate; Trials Confirm Strong Pharmacokinetic Profile Of PRO-571

August 17, 2006
·
1 min read
Drug Development

Omrix Biopharmaceuticals, Inc. Announces U.S. Phase III Clinical Trial For Intravenous Immunoglobulin (IVIG) In Subjects With Primary Immune Deficiency Diseases

August 17, 2006
·
1 min read
Drug Development

The New England Journal of Medicine Publishes Results Of Cubist Pharmaceuticals, Inc.'s Landmark Study Of Staphylococcus Aureus Blood Stream Infections; Study Results Led To Recent Label Expansion For CUBICIN

August 17, 2006
·
1 min read
Ambrilia Biopharma Inc. Reports Further Data Suggesting PPL-100 HIV Protease Inhibitor Is A Once-Daily, Un-Boosted, First-Line Therapy To Treat A Large Spectrum Of HIV/AIDS Patients

August 17, 2006
·
1 min read
Biotech Bay

Lipid Sciences, Inc. In Compliance With Nasdaq Global Market Listing Requirements

August 17, 2006
·
1 min read
Deals

Kendle International Completes Acquisition Of Phase II-IV Clinical Services Business Of Charles River Laboratories (Massachusetts)

August 17, 2006
·
3 min read